Futura Medical PLC (AIM:FUM, OTC:FAMDF) has secured a $5 million milestone payment following the US launch of its flagship product, Eroxon.
The payment was triggered as Haleon, the company’s distribution partner, began fulfilling online pre-orders and making fast-acting erectile dysfunction gel available in American retail stores. Futura expects to receive the funds shortly.
Eroxon is the first over-the-counter ED treatment to go on sale in the States.